Intercept Pharmaceuticals Inc. (ICPT) is primed for evolution with the beta value of 1.37 – Invest Chronicle

Intercept Pharmaceuticals Inc. (ICPT) is primed for evolution with the beta value of 1.37

Let’s start up with the current stock price of Intercept Pharmaceuticals Inc. (ICPT), which is $17.56 to be very precise. The Stock rose vividly during the last session to $17.64 after opening rate of $16.13 while the lowest price it went was recorded $16.13 before closing at $16.08.Recently in News on September 21, 2021, Intercept to Present at the 2021 Cantor Virtual Global Healthcare Conference. Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, today announced that Jerry Durso, President and Chief Executive Officer of Intercept, M. Michelle Berrey, M.D., M.P.H., President of Research & Development and Chief Medical Officer of Intercept, Linda Richardson, Chief Commercial Officer of Intercept, and Andrew Saik, Chief Financial Officer of Intercept, will present at the 2021 Cantor Virtual Global Healthcare Conference on Tuesday, September 28, 2021 at 8:40 a.m. ET. You can read further details here

Intercept Pharmaceuticals Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $38.94 on 01/27/21, with the lowest value was $11.60 for the same time period, recorded on 08/20/21.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


Intercept Pharmaceuticals Inc. (ICPT) full year performance was -47.86%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Intercept Pharmaceuticals Inc. shares are logging -56.55% during the 52-week period from high price, and 51.38% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $11.60 and $40.41.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1192848 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Intercept Pharmaceuticals Inc. (ICPT) recorded performance in the market was -28.91%, having the revenues showcasing 1.97% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 573.33M, as it employees total of 498 workers.

Specialists analysis on Intercept Pharmaceuticals Inc. (ICPT)

During the last month, 0 analysts gave the Intercept Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 16.90, with a change in the price was noted +0.29. In a similar fashion, Intercept Pharmaceuticals Inc. posted a movement of +1.68% for the period of last 100 days, recording 873,282 in trading volumes.

>> 7 Top Picks for the Post-Pandemic Economy << 

Trends and Technical analysis: Intercept Pharmaceuticals Inc. (ICPT)

Raw Stochastic average of Intercept Pharmaceuticals Inc. in the period of last 50 days is set at 98.68%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 97.67%. In the last 20 days, the company’s Stochastic %K was 68.31% and its Stochastic %D was recorded 43.83%.

Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -28.91%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -17.98%, alongside a downfall of -47.86% for the period of the last 12 months. The shares increased approximately by 21.78% in the 7-day charts and went up by 18.81% in the period of the last 30 days. Common stock shares were driven by 1.97% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

More Posts

Get The Best Stocks To Trade Every Day!

Join now to get the pre-market morning brief 100% free



Download Free eBook For


100% free. stop anytime no spam



Download Free eBook For


100% free. stop anytime no spam